CALL - SPRINTER OPEN END - AMGEN | Market Closed - Deutsche Boerse AG 14:01:49 2024-07-05 EDT | ||
| 8.45 EUR | +2.05% |
|
| Current month | -3.98% | ||
| 1 month | +0.72% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 8.45 | +2.05% |
| 24-07-04 | 8.28 | -1.08% |
| 24-07-03 | 8.37 | -2.56% |
| 24-07-02 | 8.59 | 0.00% |
| 24-07-01 | 8.59 | -2.39% |
Delayed Quote Deutsche Boerse AG
Last update July 05, 2024 at 02:01 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VV16YA |
| ISIN | DE000VV16YA3 |
| Date issued | 2022-05-06 |
| Strike | 220.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.49 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.48 € |
|---|---|
| Lowest since issue | 0.88 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Certificates
- Certificat
